The new decade marked a period of consolidation, growth and renewed visibility for the EACPT.
In 2009, Prof. David Webb and Prof. Simon Maxwell organised the IX EACPT Congress in Edinburgh, which attracted more than 800 delegates from five continents.
This was followed by the X EACPT Congress in Budapest in 2011, chaired by Prof. Adam Vas. Prof. Vas, who passed away in 2014, remains warmly remembered. The Budapest Congress was also highly successful financially and contributed significantly to strengthening the Association’s future development.
These consecutive successes enabled the EACPT to launch an ambitious programme aimed at increasing its visibility and enhancing the participation of European Clinical Pharmacology in the Association’s activities.
During this period, the Executive Committee underwent substantial changes. Prof. Gonzalo Calvo was appointed Chair, with Prof. Tabassome Simon as Vice-Chair. Prof. Donald Singer served as Secretary and Prof. Kari Kivisto as Treasurer. At the same time, the EACPT Council approved renewed Statutes and by-laws, which were to come into force following formal registration under German law.
The following Congress, held in Geneva and chaired by Prof. Dayer, was organised by Dr Marie Besson and Dr Caroline Samer. Despite the difficult global economic context, the meeting attracted more than 600 participants and was considered a highly successful and stimulating event.
At that meeting, the EACPT Council elected Prof. Tabassome Simon as Chair-elect and approved a strategic plan introducing new approaches to strengthen networking capacity and increase the visibility of the society.
In 2009, Prof. David Webb and Prof. Simon Maxwell organised the IX EACPT Congress in Edinburgh, which attracted more than 800 delegates from five continents.
This was followed by the X EACPT Congress in Budapest in 2011, chaired by Prof. Adam Vas. Prof. Vas, who passed away in 2014, remains warmly remembered. The Budapest Congress was also highly successful financially and contributed significantly to strengthening the Association’s future development.
These consecutive successes enabled the EACPT to launch an ambitious programme aimed at increasing its visibility and enhancing the participation of European Clinical Pharmacology in the Association’s activities.
During this period, the Executive Committee underwent substantial changes. Prof. Gonzalo Calvo was appointed Chair, with Prof. Tabassome Simon as Vice-Chair. Prof. Donald Singer served as Secretary and Prof. Kari Kivisto as Treasurer. At the same time, the EACPT Council approved renewed Statutes and by-laws, which were to come into force following formal registration under German law.
The following Congress, held in Geneva and chaired by Prof. Dayer, was organised by Dr Marie Besson and Dr Caroline Samer. Despite the difficult global economic context, the meeting attracted more than 600 participants and was considered a highly successful and stimulating event.
At that meeting, the EACPT Council elected Prof. Tabassome Simon as Chair-elect and approved a strategic plan introducing new approaches to strengthen networking capacity and increase the visibility of the society.